What is Marpai?
Marpai operates as a sophisticated AI-driven health technology enterprise, specifically engineered to transform the landscape of third-party administration. By utilizing deep learning and advanced artificial intelligence, the company addresses the inefficiencies inherent in the self-funded market. Its platform is designed to predict near-term health challenges, thereby facilitating proactive intervention and illness prevention. Furthermore, the company optimizes the patient journey by guiding members toward high-quality providers, which directly correlates to improved clinical outcomes and reduced administrative overhead. Through the application of SMART automation, Marpai simplifies complex healthcare processes, making it easier for members to manage their health while simultaneously driving cost-efficiency for plan sponsors.
How much funding has Marpai raised?
Marpai has raised a total of $5M across 1 funding round:
Other Financing Round
$5M
Other Financing Round (2025): $5M with participation from JGB Management
Key Investors in Marpai
JGB Management
JGB Management Inc. is an alternative asset management firm established in 2005 that specializes in niche credit-oriented situations and strategic investment solutions.
What's next for Marpai?
Looking ahead, the strategic deployment of this capital will likely focus on expanding the company's predictive analytics engine and broadening its footprint within the enterprise health sector. As the healthcare industry increasingly pivots toward data-centric, preventative care models, Marpai is well-positioned to capture additional market share. The focus will remain on refining its deep learning algorithms to further reduce costs and improve member engagement. By maintaining a rigorous commitment to technological innovation, the company aims to redefine the standards of third-party administration, moving away from reactive processing toward a proactive, intelligence-led framework that benefits both payers and patients alike.
See full Marpai company page